Physician profile
Youssef M Kabbani
NPI 1922059559
$13,931.69
in general payments reported to CMS, 2019-2025
29 companies · $8,142 in 2025
The $8,142 reported for 2025 was more than what 95% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $770 · 2020: $442 · 2021: $1,038 · 2022: $795 · 2023: $447 · 2024: $2,298 · 2025: $8,142.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,463 · Consulting Fee: $4,106 · Travel and Lodging: $317.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,463.39 |
| Consulting Fee | $4,106.25 |
| Travel and Lodging | $316.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $9,039.21 | 2024-2025 | |
| Stryker Corporation | $855.75 | 2021-2025 | Biofoam, Citrefix, Ortholoc 3di |
| Integra Lifesciences Corporation | $849.08 | 2019-2022 | |
| Smith+Nephew, INC. | $638.32 | 2019-2025 | Collagenase Santyl |
| Organogenesis INC. | $587.45 | 2019-2024 | Puraply |
| Wright Medical Technology, INC. | $341.39 | 2019-2020 | |
| Abbott Laboratories | $227.09 | 2023-2024 | Proclaim |
| Kerecis Limited | $206.01 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Paratek Pharmaceuticals, INC. | $200.75 | 2025 | Nuzyra |
| Novus Surgical Consultants | $186.39 | 2024-2025 | |
| Zynex Medical, INC. | $173.29 | 2025 | Nexwave |
| Convatec INC. | $167.74 | 2023-2024 | |
| Liberty Surgical INC. | $79.70 | 2021-2022 | |
| Zimmer Biomet Holdings, INC. | $46.21 | 2023-2024 | Nextremity General Instrument, Max Vpccannulated Drill, Arcus Staple System |
| Novus Surgical Solutions LLC | $42.42 | 2021 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $41.00 | 2022 | |
| Tactile Systems Technology INC | $33.95 | 2024 | Entre Plus, Flexitouch Plus |
| Medtronic, INC. | $31.70 | 2025 | Inceptiv |
| Paragon 28, INC. | $27.47 | 2023-2024 | Jaws, Tenotac |
| Boston Scientific Corporation | $24.15 | 2019 | |
| Averitas Pharma INC. | $18.97 | 2024 | Qutenza |
| Abbvie INC. | $18.70 | 2024 | |
| Acera Surgical, INC. | $16.82 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $16.72 | 2023 | Seglentis |
| International Rehabilitative Sciences, INC | $14.79 | 2025 | Rs-4i Plus With Intersperse |
| Nabriva Therapeutics, Plc | $13.01 | 2021 | |
| Merck Sharp & Dohme LLC | $11.90 | 2019 | |
| Alexion Pharmaceuticals, INC. | $11.75 | 2019 | |
| Orthofix Medical, INC. | $9.96 | 2025 | Physio-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Youssef Kabbani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.